Indian contract research services firm Suven Life Sciences Ltd has secured another patent from the European Patent Office (EPO) for lead molecule which has a potential to treat neurodegenerative diseases.

KM-391, an experimental drug being developed by Cellceutix Corporation, has shown promise in autism treatment, the company announced.

Mipomersen can cut cholesterol levels in high risk group patients, according to study data from Genzyme Corp and Isis Pharmaceuticals Inc.

Immuron has started phase II clinical trial of its immunotherapy product for the treatment of metabolic syndrome and nonalcoholic steatohepatitis (NASH), the company announced.

Ranbaxy has entered into a technology pact with Pfenex Inc to develop a biosimilar therapeutic.

NOV-205, an experimental drug to treat hepatitis C developed by Novelos Therapeutics, Inc, is currently undergoing clinical studies.

DPP (Dual Path platform) oral test to detect HIV 1&2 virus infections by Chembio Diagnostics has been approved to be included on the list of approved rapid HIV tests by the U.S. Agency for International Development (USAID).

Indian generic firm Glenmark has received final approval for generic calcipotriene (Dovonex) ointment 0.005%, from the US FDA.

APD916, an experimental drug to treat narcolepsy and cataplexy developed by Arena Pharmaceuticals, is undergoing first-in-man studies.

The European drug regulatory watchdog has recommended recall of generic blood-thinning drug clopidogrel (Plavix) manufactured in Indian facility owned by Glochem Industries Ltd alleging quality problems.